GMED Share Price

Open 23.13 Change Price %
High 23.72 1 Day 0.29 1.24
Low 23.04 1 Week 1.83 8.41
Close 23.60 1 Month 1.27 5.69
Volume 1257988 1 Year -2.72 -10.33
52 Week High 28.60
52 Week Low 19.25
GMED Important Levels
Resistance 2 24.23
Resistance 1 23.97
Pivot 23.45
Support 1 23.23
Support 2 22.97
NYSE USA Most Active Stocks
BAC 22.57 1.85%
BAC 22.57 1.85%
BAC 22.57 1.85%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
CHK 7.58 0.00%
More..
NYSE USA Top Gainers Stocks
IPI 2.49 36.81%
IPI 2.49 36.81%
IPI 2.49 36.81%
POM 26.93 26.79%
POM 26.93 26.79%
VRS 6.20 15.24%
VRS 6.20 15.24%
CVI 21.14 14.33%
SAB 7.20 12.50%
SAB 7.20 12.50%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Globus Medical, Inc. (NYSE: GMED)

GMED Technical Analysis 4
As on 7th Dec 2016 GMED Share Price closed @ 23.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 23.58 & Strong Buy for SHORT-TERM with Stoploss of 22.24 we also expect STOCK to react on Following IMPORTANT LEVELS.
GMED Target for December
1st Target up-side 23.57
2nd Target up-side 24.93
3rd Target up-side 26.29
1st Target down-side 19.71
2nd Target down-side 18.35
3rd Target down-side 16.99
GMED Other Details
Segment EQ
Market Capital 1372512512.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.globusmedical.com
GMED Address
GMED
2560 General Armistead Avenue
Audubon, PA 19403
United States
Phone: 610-930-1800
Fax: 610-930-2042
Interactive Technical Analysis Chart Globus Medical, Inc. ( GMED NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Globus Medical, Inc.
GMED Business Profile
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. It offers approximately 120 products that address an array of spinal pathologies, anatomies, and surgical approaches. The company’s fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies; and interventional pain management solutions, including treatments for vertebral compression fractures. The company has received pre-market approval for SECURE-C Cervical Artificial Disc; and conducting other clinical trials for ACADIA Facet Replacement System, a motion preserving anatomic reconstruction of the facet joint intended for the treatment of spinal stenosis, as well as TRIUMPH Lumbar Disc, a motion preserving disc replacement inserted obliquely into the disc space from a posterolateral approach to address posterior spinal pathology and maintain important anterior anatomical structures. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals. The company markets and sells its products through sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.